Nav: Home

Calixarenes in lipase biocatalysis and cancer therapy

August 17, 2016

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry. These, supramolecular structures have been utilized in several different directions ranging from catalysis to therapy. Their multifactorial significance originates from their structural plasticity and the fact that they can be easily derivatized and manipulated to adapt and complement a mosaic of different specifications and applications. This paper provides an overview of the utilization of calixarenes in biocatalysis and cancer therapy and diagnosis. Several different examples are presented on the capacity of calixarenes to enhance the stereo- and regio-selectivity as also the catalytic potency of lipases. This ability of calixarenes to amplify, upon hosting different enzymes their catalytic capacity, can be fruitfully explored to develop novel therapeutics. Calixarenes can also facilitate and decrease the time required for the synthesis of complex molecules. This potential is further advanced upon appropriate formulation with magnetic nanoparticles that can ease the regeneration and separation of the biocatalyst from the reaction mixture. Such developments are especially important in complex diseases such as cancer, where there is an immense need of novel therapeutics as also drug formulations. Due to the ability of calixarenes to be tailored with different functional groups they can accommodate different cytotoxic agents and thus can serve as drug delivery vehicles. Through such formulations the pharmacokinetic profile of the original drug is refined. Calixarenes have also obliged as drug delivery machineries that are responsive to the tumor microenvironment and a selective release of the drug to cancer cells has been achieved. Besides cancer treatment calixarenes have also served as promising diagnostic biomarkers for early stage cancer. The reported examples highlighted in this work illuminate the applicability of calixarenes to advance the field of biocatalysis and cancer therapeutics and diagnostics. This intriguing scaffold and its associated plasticity should be further explored to model the construction of multifunctional and smart molecular machineries that could assist the synthesis of novel complex scaffolds and theranostics.
-end-
Reference: Karakurt, S.; et al. (2016). Calixarenes in Lipase Biocatalysis and Cancer Therapy, Curr. Org. Chem., DOI: 10.2174/1385272820666151211192249

For more information about the article, please visit http://benthamscience.com/journals/current-organic-chemistry/article/137782/

Bentham Science Publishers

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...